Drug Safety View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1986

PUBLISHER

Springer International Publishing

LANGUAGE

en

HOMEPAGE

https://link.springer.com/journal/40264

Recent publications latest 20 shown

  • 2022-11-18 Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database
  • 2022-11-17 Development and Evaluation of the Algorithm CErtaInty Tool (ACE-IT) to Assess Electronic Medical Record and Claims-based Algorithms’ Fit for Purpose for Safety Outcomes
  • 2022-11-11 Potential Risk Factors of Drug-Related Problems in Hospital-Based Mental Health Units: A Systematic Review
  • 2022-11-11 Fully Liquid MenACWY-CRM Vaccine: Results from an Integrated Safety Analysis
  • 2022-11-09 Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience
  • 2022-11-01 Topiramate Utilization After Phentermine/Topiramate Approval for Obesity Management: Risk Minimization in the Era of Drug Repurposing
  • 2022-11-01 Detectability of Medication Errors With a STOPP/START-Based Medication Review in Older People Prior to a Potentially Preventable Drug-Related Hospital Admission
  • 2022-10-30 Characterization of Serous Retinopathy Associated with Cobimetinib: Integrated Safety Analysis of Four Studies
  • 2022-10-26 Compliance with Prescribing and Dispensing Conditions for Valproate and Related Substances in Girls and Women of Childbearing Potential: A Survey of Community Pharmacists in France
  • 2022-10-26 A Population-Based Study of SGLT2 Inhibitor-Associated Postoperative Diabetic Ketoacidosis in Patients with Type 2 Diabetes
  • 2022-10-23 Comparison of the MOdified NARanjo Causality Scale (MONARCSi) for Individual Case Safety Reports vs. a Reference Standard
  • 2022-10-19 Acknowledgement to Referees
  • 2022-10-13 Gastrointestinal Bleeding on Oral Anticoagulation: What is Currently Known
  • 2022-10-12 Authors’ Response to Yoshihiro Noguchi’s Comment on: “A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)”
  • 2022-10-12 Comment on: "A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)"
  • 2022-10-06 Network Analysis for Signal Detection in Spontaneous Adverse Event Reporting Database: Application of Network Weighting Normalization to Characterize Cardiovascular Drug Safety
  • 2022-10-03 Prevalence, Causes and Severity of Medication Administration Errors in the Neonatal Intensive Care Unit: A Systematic Review and Meta-Analysis
  • 2022-10-02 mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study
  • 2022-09-23 Safety of Apremilast in Patients with Psoriasis and Psoriatic Arthritis: Findings from the UK Clinical Practice Research Datalink
  • 2022-09-22 Correction to: 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "alternateName": "The Official Journal of the International Society of Pharmacovigilance [ISoP]", 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "1.6699999570846558", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "1.2699999809265137", 
            "type": "Rating"
          }
        ], 
        "description": "

    The premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment, risk management and medication error prevention, Drug Safety advances the rational use of pharmacotherapy by publishing reviews and original research articles offering guidance for safe and effective drug utilization and prescribing.

    \n\n

    As a hybrid journal, Drug Safety does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice™ initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the ‘How to publish with us, including Open Access’ link below.
    \n
    \nDrug Safety offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

    \n\n

    Drug Safety is the official journal of the International Society of Pharmacovigilance.

    \n", "editor": [ { "familyName": "Joshi", "givenName": "Nitin", "type": "Person" } ], "id": "sg:journal.1096281", "inLanguage": [ "en" ], "isAccessibleForFree": false, "issn": [ "0114-5916", "1179-1942" ], "license": "Hybrid", "name": "Drug Safety", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "96281" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "9002928", "8606184", "8709214" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "342006" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "14746" ] } ], "publisher": { "name": "Springer International Publishing", "type": "Organization" }, "publisherImprint": "Adis", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1096281" ], "sdDataset": "journals", "sdDatePublished": "2022-12-01T06:58", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/journal/journal_0.jsonl", "startYear": "1986", "type": "Periodical", "url": "https://link.springer.com/journal/40264" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1096281'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1096281'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1096281'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1096281'


     

    This table displays all metadata directly associated to this object as RDF triples.

    59 TRIPLES      21 PREDICATES      27 URIs      23 LITERALS      9 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1096281 schema:alternateName The Official Journal of the International Society of Pharmacovigilance [ISoP]
    2 schema:contentRating N369cedd8abd24132b814cbd9bd921cf3
    3 N807974cc41984ef48586b8a3068ec92b
    4 schema:description <p>The premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment, risk management and medication error prevention, <em>Drug Safety</em> advances the rational use of pharmacotherapy by publishing reviews and original research articles offering guidance for safe and effective drug utilization and prescribing.</p> <p>As a hybrid journal, <em>Drug Safety</em> does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice&trade; initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the &lsquo;How to publish with us, including Open Access&rsquo; link below.<br /> <br /> <em>Drug Safety</em> offers a range of additional features designed to increase the visibility, readership and educational value of the journal&rsquo;s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager&reg;, supported by a database of international experts. This database is shared with other Adis journals.</p> <p><em>Drug Safety</em> is the official journal of the International Society of Pharmacovigilance.</p>
    5 schema:editor N17131d922aa943f2b92c6148b65380f7
    6 schema:inLanguage en
    7 schema:isAccessibleForFree false
    8 schema:issn 0114-5916
    9 1179-1942
    10 schema:license Hybrid
    11 schema:name Drug Safety
    12 schema:productId N2412e7c2118d4ae89c351cf46460ec46
    13 N5b613909fa684c2a9bbfd6d94e0ad623
    14 N646fa641cfee4dddabd2d7c16b617b33
    15 N93388ee09cae4fb7ba7540f978e0610e
    16 schema:publisher N3afb62197b7f4b10b6a373aa0742d822
    17 schema:publisherImprint Adis
    18 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1096281
    19 schema:sdDatePublished 2022-12-01T06:58
    20 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    21 schema:sdPublisher N8220a81bd75b42e085064f01f6f0f315
    22 schema:startYear 1986
    23 schema:url https://link.springer.com/journal/40264
    24 sgo:license sg:explorer/license/
    25 sgo:sdDataset journals
    26 rdf:type schema:Periodical
    27 N17131d922aa943f2b92c6148b65380f7 rdf:first Nc6edc54317cd4270967e87efe58dda9f
    28 rdf:rest rdf:nil
    29 N2412e7c2118d4ae89c351cf46460ec46 schema:name nlm_unique_id
    30 schema:value 8606184
    31 8709214
    32 9002928
    33 rdf:type schema:PropertyValue
    34 N369cedd8abd24132b814cbd9bd921cf3 schema:author N465507b15ea54d1a85013f835798b2b1
    35 schema:ratingValue 1.2699999809265137
    36 rdf:type schema:Rating
    37 N3afb62197b7f4b10b6a373aa0742d822 schema:name Springer International Publishing
    38 rdf:type schema:Organization
    39 N465507b15ea54d1a85013f835798b2b1 rdf:first sjr
    40 rdf:rest rdf:nil
    41 N5b613909fa684c2a9bbfd6d94e0ad623 schema:name nsd_ids_id
    42 schema:value 342006
    43 rdf:type schema:PropertyValue
    44 N629320ce7ecd410da1d53d929032d70c rdf:first snip
    45 rdf:rest rdf:nil
    46 N646fa641cfee4dddabd2d7c16b617b33 schema:name dimensions_id
    47 schema:value 96281
    48 rdf:type schema:PropertyValue
    49 N807974cc41984ef48586b8a3068ec92b schema:author N629320ce7ecd410da1d53d929032d70c
    50 schema:ratingValue 1.6699999570846558
    51 rdf:type schema:Rating
    52 N8220a81bd75b42e085064f01f6f0f315 schema:name Springer Nature - SN SciGraph project
    53 rdf:type schema:Organization
    54 N93388ee09cae4fb7ba7540f978e0610e schema:name era_ids_id
    55 schema:value 14746
    56 rdf:type schema:PropertyValue
    57 Nc6edc54317cd4270967e87efe58dda9f schema:familyName Joshi
    58 schema:givenName Nitin
    59 rdf:type schema:Person
     




    Preview window. Press ESC to close (or click here)


    ...